Table 1 |
|||
|
Clinical characteristics of the 182 neuroblastoma patients analyzed |
|||
|
Risk groupsa |
Patientsb |
Distribution (%)c |
|
|
|
|||
|
INSS stage |
1 |
42 |
23,1 |
|
2 |
24 |
13,2 |
|
|
3 |
23 |
12,6 |
|
|
4 |
70 |
37,9 |
|
|
4s |
23 |
13,2 |
|
|
|
|||
|
Age at diagnosis |
< = 1 year |
92 |
51,1 |
|
> 1 year |
90 |
48,9 |
|
|
|
|||
|
MYCN status |
Normal |
153 |
84,1 |
|
Amplified |
29 |
15,9 |
|
|
|
|||
|
5 years survival |
Dead |
55 |
29,7 |
|
Alive |
127 |
70,3 |
|
|
|
|||
|
a Common risk groups and categories stratifying neuroblastoma patients. b The total number of patients in each group was 182. The number of patients in each subdivision is shown. c Percentage relative to the total number of patients in each risk group. |
|||
|
Cornero et al. BMC Bioinformatics 2012 13(Suppl 4):S13 doi:10.1186/1471-2105-13-S4-S13 |
|||
